Review




Structured Review

Philips Healthcare dedicated cmr workstation
Dedicated Cmr Workstation, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/dedicated+workstation/pm41679411-47-10-13
Average 86 stars, based on 1 article reviews
dedicated cmr workstation - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

other:

Article Title: Lesion Geometry as Assessed by Optical Coherence Tomography Is Related to Myocardial Ischemia as Determined by Cardiac Magnetic Resonance Imaging
Article Snippet: CMR image analysis was conducted on a dedicated CMR workstation (ExtendedWorkspace, Philips Healthcare, Best, The Netherlands) by an experienced CMR cardiologist blinded to the results of the OCT examination.

Article Title: Cardiovascular Magnetic Resonance-based Tissue Characteristics and Clinical Outcomes in Apical Hypertrophic Cardiomyopathy.
Article Snippet: This study aimed to characterize cardiovascular magnetic resonance (CMR) tissue biomarkers in individuals with apical HCM (ApHCM) and assess their association with clinical outcomes.. Firstly, CMR imaging-derived tissue characterization parameters, including T1 and T2 relaxation times, Extracellular volume (ECV), and extent of late gadolinium enhancement (LGE), was compared between patients with ApHCM and control patients.. Secondly, composite outcome defined as non-sustained ventricular tachycardia detected on holter monitoring, implantation of an implantable cardioverter defibrillator (ICD), or hospitalization for heart failure were assessed amongst those with ApHCM.



Similar Products

86
Philips Healthcare dedicated cmr workstation
Dedicated Cmr Workstation, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/dedicated+workstation/pm41679411-47-10-13
Average 86 stars, based on 1 article reviews
dedicated cmr workstation - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
Medis dedicated cmr workstation qmass mr 7.4
Dedicated Cmr Workstation Qmass Mr 7.4, supplied by Medis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/cmr+workstation+qmass+mr+7+4/pm34476778-67-6-9
Average 90 stars, based on 1 article reviews
dedicated cmr workstation qmass mr 7.4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Philips Healthcare dedicated cmr workstation intellispace portal
Dedicated Cmr Workstation Intellispace Portal, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/cmr+workstation+philips+intellispace+portal/pmc08941830-69-6-13
Average 90 stars, based on 1 article reviews
dedicated cmr workstation intellispace portal - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Philips Healthcare dedicated cmr workstation philips intellispace portal version 11.0
<t>Cardiac</t> <t>magnetic</t> <t>resonance</t> imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.
Dedicated Cmr Workstation Philips Intellispace Portal Version 11.0, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/dedicated+cmr+workstation+philips+intellispace+portal+version+11+0/pmc08930918-35-6-9
Average 90 stars, based on 1 article reviews
dedicated cmr workstation philips intellispace portal version 11.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Circle Cardiovascular Imaging Inc workstation dedicated for cmr evaluation cmr42
<t>Cardiac</t> <t>magnetic</t> <t>resonance</t> imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.
Workstation Dedicated For Cmr Evaluation Cmr42, supplied by Circle Cardiovascular Imaging Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/cmr42/10__1161_slash_circep__118__006234-50-22-25
Average 90 stars, based on 1 article reviews
workstation dedicated for cmr evaluation cmr42 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Philips Healthcare dedicated cmr workstation view forum
<t>Cardiac</t> <t>magnetic</t> <t>resonance</t> imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.
Dedicated Cmr Workstation View Forum, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/dedicated+cmr+workstation+view+forum/pm26634930-54-9-14
Average 90 stars, based on 1 article reviews
dedicated cmr workstation view forum - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Philips Healthcare dedicated cmr-workstation extendedworkspace
<t>Cardiac</t> <t>magnetic</t> <t>resonance</t> imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.
Dedicated Cmr Workstation Extendedworkspace, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dedicated+cmr+workstation/dedicated+cmr+workstation+extendedworkspace/pmc03716884-167-5-8
Average 90 stars, based on 1 article reviews
dedicated cmr-workstation extendedworkspace - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Cardiac magnetic resonance imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.

Journal: Frontiers in Cardiovascular Medicine

Article Title: A Case Series of Myocarditis Following Third (Booster) Dose of COVID-19 Vaccination: Magnetic Resonance Imaging Study

doi: 10.3389/fcvm.2022.839090

Figure Lengend Snippet: Cardiac magnetic resonance imaging of the four patients who had myocarditis following the third dose of mRNA COVID-19 vaccination demonstrated late gadolinium enhancement (yellow arrows) and T1 mapping (lower row). Patient no. 1: Mid wall late gadolinium enhancement involving 9% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in antero- and infero-lateral segments of basal and mid ventricular short-axis view, as well as in the lateral segment of apical short-axis view. Native T1 value was 1,135 ms, and T2 value was 69.2 ms. Peak troponin was 240 ng/L, and scan delay (from COVID-19 vaccine) was 8 days. Patient no. 2: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the lateral segment of apical and in the septal segment of the basal short-axis view. Native T1 value was 1,077 ms, and T2 value was 57.5 ms. Peak troponin was 80 ng/L, and scan delay (from COVID-19 vaccine) was 40 days. Patient no. 3: Epicardial late gadolinium enhancement involving 3% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in the inferior and inferolateral segments of the basal short-axis view. Native T1 value was 1,155 ms, and T2 value was 58.1 ms. Peak troponin T was 4,967 ng/L, and scan delay (from COVID-19 vaccine) was 47 days. Patient no. 4: Mid wall late gadolinium enhancement involving 1% of the myocardium with corresponding myocardial injury in native T1 mapping imaging in inferior segments of the basal and mid-ventricular short axis view, as well as in the lateral segment of the apical short axis view. Native T1 value was 1,041 ms, and T2 value was 57.4 ms. Peak troponin T was79 ng/L, and scan delay (from COVID-19 vaccine) was 42 days. Reference (normal) values: T1: 950–1,060 ms, T2: < 57 ms, and troponin T < 13 ng/L.

Article Snippet: Data analysis was performed using a dedicated CMR workstation (Philips Intellispace Portal, version 11.0).

Techniques: Magnetic Resonance Imaging, Imaging